CoChat

NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis

Open access
Lurienne, Lise, Cervesi, Julie, Duhalde, Lola, de Gunzburg, Jean, Andremont, Antoine, Zalcman, Gérard, Buffet, Renaud, Bandinelli, Pierre-Alain · 2020 · Journal of Thoracic Oncology
Cited by 169

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

INTRODUCTION Immune checkpoint inhibitors (ICI) have dramatically improved patient outcomes in a variety of tumor types, but with variable efficacy. Recent research has suggested that antibiotic- induced disruption of the microbiota may impact ICI efficacy. METHODS We performed a systematic review and meta-analysis of studies that assessed the impact of antibiotic use on the survival of patients diagnosed with non-small-cell lung carcinoma (NSCLC) treated with ICI. We systematically searched Medline, the Cochrane Library, and major oncology conferences proceedings. Eligible studies mentioned hazard ratio (HR) or Kaplan-Meier curves for progression-free survival (PFS) or overall survival (OS) according to antibiotics exposure before and/or during ICI treatment. RESULTS We identified 23 eligible studies. The impact of antibiotics was then evaluated in 2,208 patients for PFS and 5,560 for OS. For both PFS and OS meta-analyses, the between-study heterogeneity was high (Higgins and Thompson I2 of 69% and 80%, respectively). The pooled HR was 1.47 (95% CI [1.13;1.90]) for PFS and 1.69 (95% CI [1.25; 2.29]) for OS showing a significantly reduced survival in NSCLC patients exposed to antibiotics. The median OS was reduced on average by 6.7 months (95% CI [5.1; 8.4]) in patients exposed to antibiotics. The effect appears to depend on the time window of exposure with stronger effects reported when patients took antibiotics [-60 days; +60 days] around ICI initiation. CONCLUSION In NSCLC patients, the findings of the meta-analysis indicate that antibiotic use before or during treatment with ICI leads to a median OS decreased by more than 6 months. Specifically, exposure shortly before or after ICI initiation seems to be particularly detrimental, whereas antibiotic use later during disease course does not seem to alter survival. Since PFS and OS were difficult to compare between studies because of the heterogeneity and the multiple confounders factors identified, further studies are needed to strengthen the understanding of the phenomenon.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2020.03.002

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

Metadata

Authors
Lurienne, L., Cervesi, J., Duhalde, L., de Gunzburg, J., Andremont, A., Zalcman, G., Buffet, R., & Bandinelli, P.-A.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2020-07
Volume
15
Issue
7
Pages
1147-1159
ISSN
1556-0864 (ISSN-L)
OpenAlex
W3011314376
Cited by
169
References
18
FWCI
3.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.